Updates

AutoCruitment Adds to Executive Team; Opens New Raleigh, NC Office

QHP Capital Named to 2023 TOP 50 PE Firms in The Middle Market™ List

QHP Capital Invests in COPILOT

Clinical ink Again Ranked Among Fastest-Growing Companies in North America on the 2022 Deloitte Technology Fast 500™

For Third Consecutive Year, Catalyst Clinical Research Named One of Fastest Growing Companies in Triangle

QHP Capital Forms Continuation Vehicle for Catalyst Clinical Research

QHP Capital Acquires AutoCruitment

NovaQuest Private Equity Becomes QHP Capital

NovaQuest Private Equity Announces Investment in Bend Bioscience to Broaden CoreRx Offering

Pro-ficiency Acquires Fugitive Labs

QHP Capital Acquires Lexitas Pharma Services

NovaQuest Private Equity Closes Oversubscribed Fund II at $500 Million Hard Cap

Catalyst Clinical Research Acquires Aptus Clinical to Accelerate European Expansion, Broaden Client Services, and Enhance Patient Impact

Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceuticals

CoreRx Acquires Nucelo Life Sciences

Pro-ficiency to Accelerate Growth with Major Investment from NovaQuest Private Equity

NovaQuest Private Equity Acquires CoreRx, Inc.

Catalyst Clinical Research Announces Merger with Ce3, Inc. to Form a Market-Leading Next-Generation Oncology CRO

InformedDNA Secures Growth Investment from TT Capital Partners, NovaQuest Capital Management, and Frist Cressey Ventures

NovaQuest Closes $275 Million in Its Dedicated Private Equity Fund

CutisPharma Announces Acquisition of Silvergate Pharmaceuticals, Name Change to Azurity Pharmaceuticals